Trial Profile
Evaluation Of Use of Belimumab in Clinical Practice SEttings (OBSErve) - Observations from Germany
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- Acronyms OBSErve
- Sponsors GlaxoSmithKline
- 02 May 2015 New trial record